FLUOROSCOPY X-RAY EQUIPMENT DOSE MONITORS RECOMMENDED BY FDA
This article was originally published in The Gray Sheet
Executive Summary
FLUOROSCOPY X-RAY EQUIPMENT DOSE MONITORS RECOMMENDED BY FDA to help prevent radiation overdoses during fluoroscopically-guided procedures, Bruce Burlington, director of FDA's Center for Devices and Radiological Health, told the annual meeting of the National Electrical Manufacturers Association's Diagnostic Imaging and Therapy Systems Division Sept. 19 in Edgartown, Massachusetts. FDA would like manufacturers to "incorporate equipment features which will monitor total delivered dose and make more practical the prevention of such injuries." The agency, however, currently is not planning on changing the x-ray performance standard to require dose monitors or other safety enhancements.
You may also be interested in...
Sanofi Prepares Pulmonologists As Dupixent Nears COPD Finishing Line
The French drugmaker has identified education as a key challenge ahead of its June action date for the huge-selling IL4/IL-13 inhibitor in the lung condition. An approval would make it the first biologic for the disease.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.
EU Stakeholders Devise Six-Point Plan To Improve Cross-Border Clinical Trials
Sponsors need guidance on ethics requirements and clarity around national regulations to conduct cross-border clinical trials in the EU, a multi-stakeholder forum says.